Genetic Technologies Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Genetic Technologies Limited generated cash of -$9,679,048, which is more than the previous year. Cash used in financing activities reached the amount of $2,822,393 last year. Net change in cash is therefore -$6,830,589.
Cash Flow
| 2015 | -9.69M | 1.96M | 22.86M |
|---|---|---|---|
| 2016 | -7.72M | -296.33K | -1.65K |
| 2017 | -6.81M | -143.38K | 7.11M |
| 2018 | -5.62M | -2.38K | -9.96K |
| 2019 | -6.07M | -524.46K | 3.12M |
| 2020 | -5.71M | 64.78K | 18.36M |
| 2021 | -6.55M | -642K | 13.94M |
| 2022 | -5.65M | -3.48M | -279.06K |
| 2023 | -9.72M | -311.93K | 5.91M |
| 2024 | -9.67M | 114.9K | 2.82M |
GENE Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 7.85M | 11.73M | -9.64M | 14.21M | 2.13M | 5.48M | 10.98M | 11.17M | 18.34M | 2.83M |
Operating activities | ||||||||||
Net income | -12.01M | -11.75M | -7.13M | -7.07M | -6.09M | -6.42M | -5.46M | -8.40M | -8.45M | -8.81M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 534.88K | 676.58K | 578.66K | 478.22K | 265.93K | 156.26K | 303.74K | 371.61K | 390.07K | 232.20K |
Stock-based compensation expense | 0 | 253.45K | 437.50K | 714.57K | 0 | 335.10K | 0 | 121.26K | 50.23K | 303.52K |
| Deferred income tax benefit | 0 | 253.45K | 437.50K | 714.57K | 0 | 335.10K | 0 | 121.26K | 50.23K | 303.52K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 256.21K | -1.88M | -284.97K | 29.41K | -517.38K | 124.88K | 204.50K | 84.17K | 152.34K |
Inventories | 119.42K | 72.25K | -351.43K | 14.46K | -59.52K | 27.14K | -2.97K | -226.24K | 0 | 0 |
Accounts payable | 0 | -432.36K | 2.17M | -14.99K | 695.65K | 60.17K | 47.02K | 60.12K | -342.27K | 0 |
Cash generated by operating activities | -9.67M | -9.72M | -5.65M | -6.55M | -5.71M | -6.07M | -5.62M | -6.81M | -7.72M | -9.69M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | -37K | -500K | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -32.96K | -17.55K | -96.79K | -642K | -38.1K | -50.30K | -2.38K | -234.79K | -303.46K | -192.59K |
Acquisitions Net | 0 | -486.18K | -3.47M | 0 | 37K | 0 | 0 | 52.65K | 7.13K | 2.10M |
Cash generated by investing activities | 114.9K | -311.93K | -3.48M | -642K | 64.78K | -524.46K | -2.38K | -143.38K | -296.33K | 1.96M |
Financing activities | ||||||||||
Common Stock Issued | 2.57M | 7.17M | -10.47K | 15.89M | 21.79M | 3.55M | 0 | 8.04M | 0 | 23.28M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 252.09K | -336.39K | -268.59K | -236.89K | -183.90K | 0 | 0 | 0 | 0 | 2.15M |
Cash used in financing activities | 2.82M | 5.91M | -279.06K | 13.94M | 18.36M | 3.12M | -9.96K | 7.11M | -1.65K | 22.86M |
Net Change In Cash | -6.83M | -3.88M | 21.37M | 6.68M | 12.08M | -3.35M | -5.50M | -191.43K | -7.16M | 15.51M |
Cash at end of period | 1.02M | 7.85M | 11.73M | 20.90M | 14.21M | 2.13M | 5.48M | 10.98M | 11.17M | 18.34M |
| Data source | Data source | Data source | Data source | Data source |